Newman Michael James
CIK 0001876315
CSO and DirectorDirector10% Owner
Filings
6
Latest Dec 29, 2025
Issuers covered
1
Showing
6 of 6
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +18.6% | +18.6% | +18.9% | +18.2% |
| 90 days | 2 | 100% | +37.8% | +37.8% | +37.9% | +37.6% |
| 180 days | 2 | 100% | +45.4% | +45.4% | +45.5% | +45.3% |
| 365 days | 2 | 100% | +65.2% | +65.2% | +65.8% | +64.5% |
Issuers
Companies where Newman Michael James has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | 6 | Dec 29, 2025 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|